Aggrade develops an innovative aerodynamic granulation technology to formulate pharmaceutical drugs and nutraceutical products, aiming to improve oral drug bioavailability and simplify formulation processes. The company targets extending marketed drug platforms to include agents entirely insoluble in water. Co‑founded by Giovanni Politi and Vincenzo Politi in 2013, Aggrade operates from Camberley, United Kingdom. It recently signed a deal with nutraceutic company BioDue under which BioDue will build an industrial facility to produce dietary supplements using Aggrade’s system in exchange for royalties. Aggrade intends to use new funding to conduct R&D activities and expand the business.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2016